Pancreatic Cancer Research

ResearcherKarolinska University HospitalActive in the last 2 years

Melroy Alistair D'souza

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-6798-8960; OpenAlex author ID A5004095741. Sources: OpenAlex.

Their work

Papers
4 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper · 2026: 2 papers

Papers 4

  1. Multiple R1 margins are associated with shorter overall survival: national register-based study on pancreatic cancer. Co-author DOI 10.1093/bjsopen/zrag155↗
  2. Pulmonary Metastases After Surgical Resection of Pancreatic Ductal Adenocarcinoma: Impact on Long-Term Survival and Perspectives on Targeted Treatments. Co-author DOI 10.1245/s10434-026-19586-1↗
  3. Predictors of futile surgery in upfront resectable pancreatic ductal adenocarcinoma. possible targets for neoadjuvant chemotherapy? Co-author DOI 10.1016/j.pan.2025.09.025↗
  4. Mechanisms for skeletal muscle insulin resistance in patients with pancreatic ductal adenocarcinoma. First author DOI 10.1016/j.nut.2010.08.022↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Omid Sadr‐Azodi · 2 shared papers, 2025–2026 · strength 0.72
  2. Marcus Holmberg · 2 shared papers, 2025–2026 · strength 0.72
  3. Carlos Fernández Moro · 1 shared paper, 2026 · strength 0.36
  4. Patrik Larsson · 1 shared paper, 2026 · strength 0.36
  5. Bobby Tingstedt · 1 shared paper, 2026 · strength 0.36
  6. Ernesto Sparrelid · 1 shared paper, 2026 · strength 0.36
  7. Poya Ghorbani · 1 shared paper, 2026 · strength 0.36
  8. Thorhallur Agustsson · 1 shared paper, 2011 · strength 0.04
  9. Bengt Isaksson · 1 shared paper, 2011 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.